FR2162585A1 - - Google Patents

Info

Publication number
FR2162585A1
FR2162585A1 FR7243747A FR7243747A FR2162585A1 FR 2162585 A1 FR2162585 A1 FR 2162585A1 FR 7243747 A FR7243747 A FR 7243747A FR 7243747 A FR7243747 A FR 7243747A FR 2162585 A1 FR2162585 A1 FR 2162585A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7243747A
Other languages
French (fr)
Other versions
FR2162585B1 (cg-RX-API-DMAC7.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2162585A1 publication Critical patent/FR2162585A1/fr
Application granted granted Critical
Publication of FR2162585B1 publication Critical patent/FR2162585B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7243747A 1971-12-10 1972-12-08 Expired FR2162585B1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00206932A US3846410A (en) 1971-12-10 1971-12-10 3-substituted-7-hydroxy lower alkyl benzodiazepines

Publications (2)

Publication Number Publication Date
FR2162585A1 true FR2162585A1 (cg-RX-API-DMAC7.html) 1973-07-20
FR2162585B1 FR2162585B1 (cg-RX-API-DMAC7.html) 1975-10-31

Family

ID=22768577

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7243747A Expired FR2162585B1 (cg-RX-API-DMAC7.html) 1971-12-10 1972-12-08

Country Status (11)

Country Link
US (1) US3846410A (cg-RX-API-DMAC7.html)
JP (1) JPS4864091A (cg-RX-API-DMAC7.html)
AU (1) AU468134B2 (cg-RX-API-DMAC7.html)
BE (1) BE792438A (cg-RX-API-DMAC7.html)
CA (1) CA976548A (cg-RX-API-DMAC7.html)
DE (1) DE2260446A1 (cg-RX-API-DMAC7.html)
FR (1) FR2162585B1 (cg-RX-API-DMAC7.html)
GB (1) GB1373322A (cg-RX-API-DMAC7.html)
IL (1) IL40804A (cg-RX-API-DMAC7.html)
NL (1) NL7216713A (cg-RX-API-DMAC7.html)
ZA (1) ZA727857B (cg-RX-API-DMAC7.html)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119071A1 (cg-RX-API-DMAC7.html) * 1970-12-23 1972-08-04 Hoffmann La Roche

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3176009A (en) * 1965-03-30 Hydrolysis of l-acylated-j-acyloxy benzodiazepines
US3371085A (en) * 1959-12-10 1968-02-27 Hoffmann La Roche 5-aryl-3h-1,4-benzodiazepin-2(1h)-ones
FR1447040A (fr) * 1964-09-23 1966-07-22 Hoffmann La Roche Procédé pour la préparation de dérivés de benzodiazépine
US3682892A (en) * 1970-12-23 1972-08-08 Hoffmann La Roche 7-hydroxy lower alkyl benzodiazepines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119071A1 (cg-RX-API-DMAC7.html) * 1970-12-23 1972-08-04 Hoffmann La Roche

Also Published As

Publication number Publication date
AU468134B2 (en) 1976-01-08
JPS4864091A (cg-RX-API-DMAC7.html) 1973-09-05
IL40804A0 (en) 1973-01-30
NL7216713A (cg-RX-API-DMAC7.html) 1973-06-13
CA976548A (en) 1975-10-21
GB1373322A (en) 1974-11-13
FR2162585B1 (cg-RX-API-DMAC7.html) 1975-10-31
ZA727857B (en) 1973-07-25
BE792438A (fr) 1973-06-08
AU4881672A (en) 1974-05-16
US3846410A (en) 1974-11-05
IL40804A (en) 1975-12-31
DE2260446A1 (de) 1973-06-14

Similar Documents

Publication Publication Date Title
FI50611B (cg-RX-API-DMAC7.html)
DK135330C (cg-RX-API-DMAC7.html)
FR2119785A5 (cg-RX-API-DMAC7.html)
CS168576B2 (cg-RX-API-DMAC7.html)
DK130308C (cg-RX-API-DMAC7.html)
FR2144637A2 (cg-RX-API-DMAC7.html)
FI46775B (cg-RX-API-DMAC7.html)
FR2162585B1 (cg-RX-API-DMAC7.html)
FR2101866A5 (cg-RX-API-DMAC7.html)
DE2124106A1 (cg-RX-API-DMAC7.html)
CS153243B1 (cg-RX-API-DMAC7.html)
CS151789B1 (cg-RX-API-DMAC7.html)
CS151283B1 (cg-RX-API-DMAC7.html)
CS151619B1 (cg-RX-API-DMAC7.html)
CS156283B1 (cg-RX-API-DMAC7.html)
CS163483B1 (cg-RX-API-DMAC7.html)
CS178104B2 (cg-RX-API-DMAC7.html)
CS148671B1 (cg-RX-API-DMAC7.html)
CS168907B1 (cg-RX-API-DMAC7.html)
CS162885B1 (cg-RX-API-DMAC7.html)
BG16839A1 (cg-RX-API-DMAC7.html)
BG16655A1 (cg-RX-API-DMAC7.html)
CH574470A5 (cg-RX-API-DMAC7.html)
CH606033A5 (cg-RX-API-DMAC7.html)
DD96624A1 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
ST Notification of lapse